L-DOPA reduces harmful beta-amyloid plaques in AD model mice (IMAGE)
Caption
(Top) Schematic of the Alzheimer's disease model mouse brain. Green dots represent amyloid-beta plaques. (Bottom) Experimental results after treating the model mice with placebo or L-DOPA for 3 months. Note the reduction in beta-amyloid (fluorescently labeled in green) in both frontal and posterior cortices after treatment.
Credit
RIKEN
Usage Restrictions
None
License
Original content